California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts

The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.

from NYT > Health https://ift.tt/j7oD420